Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
Zhi Shi,
Ning Wang,
Ying-Jie Zhang,
Yi-Chao Zheng,
Yi-Chao Zheng,
Yi-Chao Zheng
Affiliations
Zhi Shi
Department of Cell Biology & Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provincial Key Laboratory of Bioengineering Medicine, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong, China
Ning Wang
School of Chinese Medicine, The University of Hong Kong, Hong Kong, China
Ying-Jie Zhang
MOE Key Laboratory of Chemical Biology, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China
Yi-Chao Zheng
Collaborative Innovation Centre of New Drug Research and Safety Evaluation, Zhengzhou, Henan Province, China
Yi-Chao Zheng
Key Laboratory of Advanced Drug Preparation Technologies, Zhengzhou University, Zhengzhou, Henan Province, China
Yi-Chao Zheng
MOE Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhenghzou University, Zhengzhou, Henan Province, China